Inhibrx Biosciences, Inc. (INBX)
NASDAQ:INBX
Want to see INBX full AI Analyst Report?
Inhibrx Biosciences Inc (INBX) Ownership Overview
9.66% Insiders
8.25% Mutual Funds
45.63% Other Institutional Investors
10.77% ETFs
25.69% Public Companies and
Individual Investors
The ownership structure of Inhibrx Biosciences Inc (INBX) stock is a mix of institutional, retail, and individual investors. Approximately 64.65% of the company’s stock is owned by Institutional Investors, 9.66% is owned by Insiders, and 25.69% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Oct 09, 2025 | xxxxxxxxxxxxx | $11287500 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2024 | xxxxxxxxxxxxx | $96993192 | |
Jun 30, 2024 | xxxxxxxxxxxxx | $25845431 | |
Jun 30, 2024 | xxxxxxxxxxxxx | $352420 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,442,707 | Institution | 9.83% | 125,529,936 | |
| 1,437,705 | Institution | 9.80% | 125,094,712 | |
| 1,059,046 | Insider | 7.22% | 92,147,592 | |
| 562,250 | Institution | 3.83% | 48,921,373 | |
| 472,619 | Institution | 3.22% | 41,122,579 | |
| 438,510 | Institution | 2.99% | 38,154,755 | |
| 384,433 | Institution | 2.62% | 33,449,515 | |
| 379,208 | Institution | 2.58% | 32,994,888 | |
| 353,292 | Institution | 2.41% | 30,739,937 | |
| 224,564 | Insider | 1.53% | 19,539,314 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 472,619 | Institution | 3.22% | 41,122,579 | |
| 353,292 | Institution | 2.41% | 30,739,937 | |
| 99,037 | Institution | 0.68% | 8,617,209 | |
| 91,375 | Institution | 0.62% | 7,950,539 | |
| 52,268 | Institution | 0.36% | 4,547,839 | |
| 27,799 | Institution | 0.19% | 2,418,791 | |
| 16,460 | Institution | 0.11% | 1,432,185 | |
| 16,242 | Institution | 0.11% | 1,413,216 | |
| 16,182 | Institution | 0.11% | 1,407,996 | |
| 11,882 | Institution | 0.08% | 1,033,853 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 369,641 | Institution | 2.52% | 47,761,314 | |
| 325,183 | Institution | 2.22% | 29,672,949 | |
| 215,021 | Institution | 1.47% | 18,708,977 | |
| 109,420 | Institution | 0.75% | 14,138,158 | |
| 78,303 | Institution | 0.53% | 6,813,144 | |
| 74,625 | Institution | 0.51% | 6,493,121 | |
| 74,332 | Institution | 0.51% | 6,467,627 | |
| 45,820 | Institution | 0.31% | 5,920,402 | |
| 42,899 | Institution | 0.29% | 3,732,642 | |
| 37,191 | Institution | 0.25% | 3,393,679 |
FAQ
Who Owns Inhibrx Biosciences, Inc. (INBX)?
According to the latest TipRanks data, approximately 45.63% of the company's stock is held by institutional investors, 9.66% is held by insiders, and 25.69% is held by retail investors.
What percentage of Inhibrx Biosciences, Inc. (INBX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 45.63% of Inhibrx Biosciences, Inc. (INBX) stock is held by institutional investors.
What percentage of Inhibrx Biosciences, Inc. (INBX) stock is held by retail investors?
According to the latest TipRanks data, approximately 25.69% of Inhibrx Biosciences, Inc. (INBX) stock is held by retail investors.
Who owns the most shares of Inhibrx Biosciences, Inc. (INBX)?
Joseph Edelman owns the most shares of Inhibrx Biosciences, Inc. (INBX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.